Niacin-like reaction to infliximab infusion in systemic juvenile rheumatoid arthritis.
Becker
Mara
M
Rosé
Carlos D
CD
McIlvain-Simpson
Gail
G
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D005483:Flushing / Q000139:chemically induced; D005500:Follow-Up Studies; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D009525:Niacin / Q000009:adverse effects; D018570:Risk Assessment; D012494:Sampling Studies
D000911:Antibodies, Monoclonal; D009525:Niacin; D000069285:Infliximab